Skip to main content

3 Result(s)

within Hjalmar Flygt Remove this filter Hematology Remove this filter

and

  1. Article

    Open Access

    Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial

    Hjalmar Flygt, Stina Söderlund, Johan Richter, Susanne Saussele… in Leukemia (2024)

    Download PDF (333 KB) View Article

  2. Article

    Open Access

    Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial

    Tyrosine kinase inhibitor (TKI) discontinuation in chronic myeloid leukemia (CML) has become part of routine care for patients with a sustained deep molecular response (DMR). Approximately 50% experience a mol...

    Hjalmar Flygt, Stina Söderlund, Johan Richter, Susanne Saussele… in Leukemia (2024)

    Download PDF (1064 KB) View Article

  3. Article

    Open Access

    The impact of Covid-19 in patients with chronic myeloid leukemia—a nationwide population-based study

    Torsten Dahlén, Hjalmar Flygt, Anna Lübking, Ulla Olsson-Strömberg… in Leukemia (2023)

    Download PDF (383 KB) View Article